NCT04954651

Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received European Union (EU) -Approved COVID-19 Vaccines

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (actual)
• Sponsor: University of Patras · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Conditions

• SARS-CoV2 Infection
• Vaccine Reaction

Interventions

Type	Name	Description
BIOLOGICAL	Approved vaccines against Sars-Cov2	Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU

Timeline

• Start date: 2021-07-07
• Primary completion: 2022-03-28
• Completion: 2022-03-28
• First posted: 2021-07-08
• Last updated: 2022-06-06

Locations

1 site across 1 country: Greece